Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories in the SPARCL Trial
J Am Coll Cardiol 2020 Mar 11;[EPub Ahead of Print], M Szarek, P Amarenco, A Callahan, D DeMicco, R Fayyad, LB Goldstein, R Laskey, H Sillesen, KM WelchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.